We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Hurry up

20 July 2007 By Robert Cyran

The medical device group s $27bn Guidant purchase last year left it drowning in debt. Now, its two big business lines are suffering. Restrictive debt covenants and principal payments may cause a crunch. If it can t turn around its operations, it might have to sell assets.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)